Investors Say Biotech Co. Altered Alzheimer Drug Data
By Katie Buehler · January 20, 2022, 5:29 PM EST
Texas-based biotechnology company Cassava Sciences Inc. has oversold to the public and the U.S. Food and Drug Administration the efficacy of its two products that can allegedly detect signs of Alzheimer's...
To view the full article, register now.